FDA Approval To Reimbursement A Challenge For Start-Ups – Biex Founder
This article was originally published in The Gray Sheet
Executive Summary
Biex, Inc. plans to relaunch its salivary estriol test for detecting pre-term labor (PTL) with a retooled business strategy after experiencing difficulties in its initial attempts to gain sufficient reimbursement coverage
You may also be interested in...
CMS May Use Med-Tech Council To Address Small Company Concerns
The Centers for Medicare & Medicaid Services is urging small manufacturers to provide examples of new technology dissemination being stifled due to inadequate reimbursement
CMS May Use Med-Tech Council To Address Small Company Concerns
The Centers for Medicare & Medicaid Services is urging small manufacturers to provide examples of new technology dissemination being stifled due to inadequate reimbursement
Biex To Educate Clinicians/Payers On SalEst Cost Benefits Prior To Roll-Out
Biex' 40-member sales and clinical support organization is preparing for the launch of the SalEst salivary estriol test in the U.S. with a six-week education program aimed at physicians and payers on the utility of the product as an aid in identifying women at risk for preterm labor and delivery.